Fintel reports that on October 30, 2025, TD Cowen maintained coverage of FormFactor (NasdaqGS:FORM) with a Hold ...

What Happened? Shares of semiconductor testing company FormFactor (NASDAQ:FORM) jumped 23.9% in the morning session after the company reported strong third-quarter 2025 results that surpassed market ...

Q3 2025 Earnings Call October 29, 2025 4:25 PM EDTCompany ParticipantsStan Finkelstein - Head of Investor RelationsMike Slessor ...

Nearshore, the AI platform automating factory quoting and ordering across the Americas, has launched Luna AI — a conversational layer that guides brands, matches projects to suppliers, generates ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon of ...

Online quotes are the fastest way to compare car insurance rates from multiple companies. See your personalized results from 80+ companies that are competing to insure your car. Agents or online ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon of ...

It's a shame it rained so much at the end of last week and we were unable to find out whether Publish could be the next Field Of Gold. The Solario did still provide a thrilling finish, although ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

We list the best online form builders, to make it simple and easy to collect, organize and analyze website data such as customer feedback and marketing analytics. All of the best online form builders ...

Earnings call FormFactor posted Q2 2025 revenue of $195.8M, up 14.3% QoQ and above guidance, driven by strength in HBM and Foundry/Logic probe cards. However, non-GAAP gross margin of 38.5% missed ...

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. The company’s lead product ...